Medicare billing address
CMS Medicare provider billing file
161 W 200 NSuite 200
St George, UT 84770
CMS public data · NPI 1497769368
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Sharon R Richens, MD
Specialty
Credential
MD
NPI
1497769368
Primary source state
UT
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Sharon R Richens, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
161 W 200 NCMS Doctors & Clinicians file
161 W 200CMS Doctors & Clinicians file
161 W 200CMS Doctors & Clinicians file
1301 Bertha Howe AveIn the 2024 CMS provider billing file, this NPI had 942 Medicare beneficiaries and 21,782 total services. The average beneficiary age was 76, and the average HCC risk score was 1.1.
Total Medicare allowed amount
$1,485,183.71
Total Medicare payment amount
$1,158,727.79
Medicare beneficiaries
942
Total services
21,782
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
73%
CMS beneficiary-panel share
Hypertension
69%
CMS beneficiary-panel share
Diabetes
24%
CMS beneficiary-panel share
Chronic kidney disease
21%
CMS beneficiary-panel share
Ischemic heart disease
21%
CMS beneficiary-panel share
Mood disorders
20%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 15,120 | $34.61 |
| Injection, pegcetacoplan, intravitreal, 1 mg | 1,530 | $147.29 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 720 | $125.83 |
| Imaging of retina | 590 | $38.79 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 494 | $88.53 |
| Injection of drug into eye | 372 | $135.09 |
| Removal of cataract with insertion of prosthetic lens | 250 | $521.19 |
| Closure of tear duct opening using plug | 231 | $112.01 |
| Analysis of substance using immunoassay technique, multiple step method | 223 | $11.30 |
| Imaging of optic nerve | 217 | $34.03 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1497769368. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Doxycycline Hyclate | Doxycycline Hyclate | 236 | 631.5 | $6,307.31 |
| 2 | Prednisolone Acetate | Prednisolone Acetate | 180 | 219.5 | $8,402.39 |
| 3 | Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 142 | 305.8 | $2,827.66 |
| 4 | Moxifloxacin | Moxifloxacin Hcl | 137 | 138 | $2,718.60 |
| 5 | Vyzulta | Latanoprostene Bunod | 122 | 202.1 | $55,570.14 |
| 6 | Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 78 | 83.2 | $924.11 |
| 7 | Bromfenac Sodium | Bromfenac Sodium | 65 | 71.7 | $6,836.97 |
| 8 | Latanoprost | Latanoprost | 65 | 107 | $418.27 |
| 9 | Cyclosporine | Cyclosporine | 62 | 83.5 | $15,526.76 |
| 10 | Restasis | Cyclosporine | 62 | 105.5 | $61,480.21 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Utah School Of Medicine
Graduation year
1992
Group/practice field
Sharon Richens Md Eye Physician And Surgeon Pc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.